The development of my country's pharmaceutical equipment market is huge, and innovative enterprises will have a lot to do

[ Market analysis of chemical machinery equipment network ] Pharmaceutical equipment refers to special production equipment for chemical raw materials and pharmaceuticals, Chinese herbal medicines and Chinese patent medicines.
Various pharmaceutical equipment with different functions are required in each link of drug research and development and production.
For a long time, pharmaceutical equipment has played an irreplaceable role in the transformation and upgrading of the pharmaceutical industry, as well as in enhancing the competitiveness of enterprises and ensuring drug safety.

The pharmaceutical equipment market has huge room for development
 

Data shows that with the rapid development of the pharmaceutical industry in recent years, my country's pharmaceutical equipment industry has also begun to show a trend of high economic development.
In addition to the market growth rate that has maintained a growth rate of more than 20%, the market size has also increased from over 45 billion yuan in 2018 to nearly 100 billion yuan in 2019.
Driven by multiple factors such as the continuous introduction of favorable policies, the continuous influx of overseas capital, and the return of talents in large numbers, the industry predicts that the demand for pharmaceutical equipment will continue to grow, and the market size may sprint 200 billion yuan in 2021.

 

In fact, in addition to the continuous expansion of the pharmaceutical equipment industry market, the sales revenue of pharmaceutical equipment companies is also increasing.
Recently, Canaan Technology released its 2020 annual report.
During the reporting period, the company achieved operating income of 1.
007 billion yuan, a year-on-year increase of 43.
25%; net profit attributable to shareholders of listed companies was 67.
91 million yuan, a year-on-year increase of 32.
33%.
On the same day, the company also disclosed the report for the first quarter of 2021.
The report shows that the company's operating income in the first quarter was 168 million yuan, a year-on-year increase of 95.
45%.
The net profit attributable to shareholders of listed companies was 10.
7571 million yuan, a year-on-year increase of 67.
06%.

Regarding the main reason for the increase in operating income and net profit, Canaan Technology stated that it is because the company continues to strengthen the "solid preparation smart factory overall solution provider" and the strategic orientation of big health.
The company is working together and actively taking various effective measures.
Fully guarantee the advancement of pharmaceutical equipment and smart logistics industry projects.

It is worth mentioning that on the basis of such outstanding achievements, Canaan Technology stated that in the future, it will continue to promote the capacity expansion of high-end generic pharmaceutical companies and smart factory projects, the scale expansion of innovative drugs in the bio-industry, and the smart logistics industry.
, The rapid development of the drug R&D outsourcing industry, as well as the company's solid preparation smart factory business, biological preparation innovative pharmaceutical water equipment and pharmaceutical liquid dispensing system engineering business, intelligent warehousing logistics system business and pharmaceutical research and development service business, etc.
And the above business will continue to be the main driving force of the company's performance growth.

　　Innovative companies will have a lot to do
 

　　In fact, it can be clearly seen from the development status and planning of Canaan’s science and technology that with the development of intelligence, informatization, and digital technology, the extensive and sacrificial production model of pharmaceutical equipment companies in the past is gradually being eliminated, and the new model of medicine Machine technology is continuously accelerating the transformation and upgrading of intelligence, information, and digitization.

 

　　In this regard, the industry believes that the current development status of Canaan Technology is only a microcosm of the transformation of my country's pharmaceutical equipment industry to the independent R&D and innovation stage.
Under the background that innovation is productivity and the vitality of the industry and enterprises, the industry generally believes that innovative pharmaceutical equipment companies will have a lot to do in the future.
The reason for this belief is that with the intensification of industry competition and the increasing public attention to drug safety, pharmaceutical companies have put forward higher requirements for the safety, production efficiency, and stability of pharmaceutical equipment.
Speeding up technological innovation and developing towards intelligence can improve the manufacturing level and production capacity of China's pharmaceutical equipment at a higher level and on a larger scale.

 

　　At present, many companies are actually using intelligent, information, and digital technologies to accelerate the transformation and innovation of pharmaceutical equipment technology and products.
For example, Tofflon has accelerated the upgrading of pharmaceutical equipment in recent years and has continued to innovate on the basis of equipment automation.
It is understood that the overall turnkey project launched by it has covered the design of production line layout, optimization of equipment integration and multi-faceted functions of "smart pharmaceutical factory" such as automated production, digital monitoring, and information-based remote management.

 

　　In addition, in 2019, Xinma Pharmaceutical also began to construct high-end pharmaceutical equipment industrialization projects.
It is estimated that after the project is completed and put into production, the sales revenue will reach 1.
2 billion yuan and the annual profit will be 180 million yuan.
It is worth mentioning that the launch of this project will not only mean that the technological innovation of Xinma Pharmaceutical will be further upgraded, but will also make it a complete solution provider that provides stable and reliable solid preparation equipment for domestic and foreign customers.  

　　Conclusion
 

　　In general, as industry competition intensifies and the public pays more attention to drug safety, pharmaceutical companies will put forward higher requirements for the safety, production efficiency, and stability of pharmaceutical equipment.
In this context, pharmaceutical equipment companies must accelerate the improvement of equipment automation, digitization, and intelligence, and accelerate innovation and transformation, in order to better meet the ever-increasing production needs of pharmaceutical companies.

 

　　Original title: my country's pharmaceutical equipment market has huge room for development, and innovative enterprises will have a lot to do